The Asthma Devices Market is undergoing a major transformation as smart inhalers, connected respiratory devices, and digital healthcare technologies become increasingly integrated into asthma management. The market was valued at USD 4.268 billion in 2024 and is forecast to reach USD 8.72 billion by 2035, growing at a CAGR of 6.71% during 2025–2035.

Smart inhalers are emerging as an important technological opportunity because they can track medication usage and provide information that supports treatment adherence. Integration with mobile applications can allow patients to monitor their medication routines while healthcare professionals gain additional information for managing long-term respiratory care.

The digital transformation of asthma devices is also encouraging personalized treatment approaches. Asthma symptoms and treatment requirements can vary among patients, making individualized management increasingly important. Connected devices can support data-driven approaches by providing information about medication use and potentially helping patients better understand their treatment routines.

Although digitally operated devices are growing rapidly, manually operated inhaler devices continue to dominate the technology segment, holding a 72% share in 2024. Their established clinical use, simplicity, and cost-effectiveness continue to support strong demand.

Inhalers overall remain the largest product category, representing approximately 68% of the market. Nebulizers are also important, particularly for children and patients with severe asthma. The coexistence of different delivery technologies allows healthcare providers to select devices according to patient requirements and treatment circumstances.

Clinics represent the largest end-user segment, accounting for 46% of the market. Clinics play an important role in asthma diagnosis, treatment, follow-up care, and long-term monitoring. Hospitals also represent a significant setting, particularly for severe cases, while retail pharmacies are becoming increasingly important distribution channels.

North America maintains a leading position with approximately 40% of the global market. The region's advanced healthcare infrastructure and strong demand for innovative respiratory technologies provide favorable conditions for smart asthma devices. Asia-Pacific is another promising market, supported by healthcare infrastructure development, increasing urbanization, air pollution concerns, and growing digital health adoption.

As healthcare becomes increasingly connected, the Asthma Devices Market is expected to benefit from artificial intelligence, IoT-enabled devices, mobile applications, remote monitoring, and telehealth integration. These developments can create new opportunities for companies developing next-generation respiratory management technologies.